New journal devoted to gene therapy and human genetics

The Gene Therapy Review (GTR) is pleased to announce the launch of its first print edition as of 31st July 2009.

The Gene Therapy Review was first launched in 2008 as an online source of information on all aspects of gene therapy with sections comprising information on gene therapy research, news, disease targets, patient resources and companies offering services to the gene therapy community. It then further featured a clinical trials database detailing all gene therapy clinical procedures completed to date.

Consequently, the Gene Therapy Review started to invite scientists to submit review articles on any aspect of gene therapy research, which was to prove an immediate success with researchers in the field. Then in February 2009, an agreement was signed with the EBSCO publishing group, with a view to include the submitted articles on the EBSCOhost databases, which are distributed to school, college, university, hospital, governmental, corporate and public libraries worldwide.

The print edition of the Gene Therapy Review will be published on a biannual basis and will include all the educational content submitted to the genetherapyreview.com website by members of the scientific community. Editor-in-Chief of the GTR, Dr Michael Roberts explains "This is a very exciting period for us. We were honoured when EBSCO publishing approached us and asked to include our content on their databases. From then it seemed like a natural progression to prepare a print edition and move towards becoming a peer-reviewed journal with a view to be included in journal databases such as PubMed."

Users can download GTR articles in PDF for free, or can subscribe to the print edition on the genetherapyreview.com website.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers uncover key genes linked to DCIS progression